CASI - CASI Pharmaceuticals GAAP EPS of -$0.45 revenue of $8.35M May, 17 2023 08:06 AM CASI Pharmaceuticals Inc. 2023-05-17 08:06:14 ET CASI Pharmaceuticals press release ( NASDAQ: CASI ): Q1 GAAP EPS of -$0.45. Revenue of $8.35M (-7.8% Y/Y). For further details see: CASI Pharmaceuticals GAAP EPS of -$0.45, revenue of $8.35M